Excited to see our first-ever #CKM syndrome guidelines out—a herculean effort to distill the evidence and advance care. Ensuring that high-quality care is available to all will require strategic investments in access and #affordability. @SmithBIDMC
Identification and management of non-obstructive high-risk coronary artery plaque
Please read the article and enjoy an in-depth interview between @jhfrudd and the first author, University of Edinburgh's Dr Craig Balmforth
Publication - https://t.co/j3ZQk2CNPa
Podcast - https://t.co/qPPLSvTdhj
I sat down with my mentor Dr. Eugene Braunwald for a 3 part series about his life.
In part 1 we talk about his early years:
"Everything changed on March 12, 1938 when Hitler marched in with the Nazis & my father was arrested"
Hear how they escaped here
For better video quality view here: https://t.co/1l3DhounN4
We are deeply saddened to have lost our founding chairman and the father of modern academic cardiology, Dr. Eugene Braunwald, who founded the TIMI Study Group in 1984, and with that vision profoundly shaped the practice of cardiovascular medicine across the world.
STEMI-DTU trial: Combination of the Impella CP plus device a 30-minute delay to PCI did not reduce infarct size vs. immediate PCI in patients with anterior STEMI without shock. #ACC26 View slides here: https://t.co/yzmg7CwT0k
Presented at #ACC26:
In patients with atrial fibrillation, left atrial appendage closure was noninferior to NOACs in an analysis of death from cardiovascular causes, stroke, or systemic embolism and was superior for non–procedure-related bleeding. Full CHAMPION-AF trial results: https://t.co/5Uv4N1HXXn
Editorial: Left Atrial Appendage Closure — Should Recommendations Be Expanded? https://t.co/afTN59ySIA
@ACCinTouch
The era of the GLP-1 family of drugs is still in the early days. These gut peptides talk to the brain and immune system and there are so many more in development, in combination, in pills, to come.
Wonderful to host @DrCaliff_FDA - our visiting "chief provocateur" - for @SmithBIDMC Grand Rounds @BidmcCvi
A rich and thought-provoking discussion on health care, social inequality, public health, and the role of communication & trust.
@ChrisKramerMD high yield talk (a thread 1/4) AN(O)CA, INOCA & MINOCA – umbrella terms for patients with non-obstructive CAD (<50% stenosis).
•MINOCA: MI + troponin elevation + angina
•INOCA: Ischemia + angina, no troponin
•ANOCA: Angina only
#ACCMidEast@ACCinTouch
🚨 A new, practical framework for evaluating the economic value of cardiovascular drugs, devices, and preventive strategies
Just published in @JACCJournals and @CircAHA
Here’s what’s new, why it matters, and how it will shape care. 🧵
2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | JACC https://t.co/JN1Bs4Paf7
#ESCCongressVisuals from Hot Line 8👇
Will the ALONE-AF trial demonstrate that patients with AF who have at least one non-gender stroke risk factor & no documented recurrence of AF after 12 months receiving apixaban have a lower composite of stroke, systemic embolism and bleeding? 👇
PFA has gained traction given its simplicity recently. Will the BEAT PAROX AF trial prove that this technology provides superior results compared with the previously employed ablation techniques? 👇
Are we charting the future of more precise ablation using digital twin-guided rotor ablation? The CUVIA-PRR brings the future to us today. 👇
#ESCCongress
@ISACHD#Case of the #Month
Congratulations to 🇨🇴 team @fcardioinfantil
1/ 🫀
A 27-year-old woman with a history of dextro-transposition of the great arteries (D-TGA) repaired by Mustard procedure as an infant develops worsening shortness of breath.
What happened next shows the power of multimodal imaging & multidisciplinary teamwork.
#CardioTwitter #ACHD